Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $9.00, but opened at $8.60. Oxford BioMedica shares last traded at $8.6301, with a volume of 11,000 shares traded.
Oxford BioMedica Price Performance
The firm’s 50-day moving average is $8.10 and its 200-day moving average is $9.02.
About Oxford BioMedica
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Recommended Stories
- Five stocks we like better than Oxford BioMedica
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo-1200x675.png){kind=logo}
